by Tara Fernandez | Jan 13, 2022
Cells that are programmed to protect can sometimes go rogue, as is the case with multiple sclerosis, or MS. Overactive immune cells mistakenly target the tissues of the brain, spinal cord and optic nerves, igniting inflammatory flare-ups that destroy myelin, a fatty...
by Lyla El-Fayomi | Dec 17, 2021
Each of the following research stories are highlights selected from previous editions of “Regenerative Medicine News Under the Microscope.” Vote for the one that inspired you most this year! Vision science: Making organoids cry This story is nothing to...
by Cal Strode | Dec 1, 2021
To mark World AIDS Day, I caught up with the International AIDS Society (IAS) 2021 HIV Cure and Gene Therapy Forum’s opening session, which focused on the intersection between HIV cure research and rapidly advancing gene-based therapies. The session sought to address...
by Stacey Johnson | Nov 12, 2021
In 2016 I shared a list of podcasts that I thought Signals’ readers might enjoy. I think it’s definitely time to update that list, and I’m excited to tell you about a new podcast that’s about to launch: Commercializing Living Therapies with CCRM. Commercializing...
by Lyla El-Fayomi | Nov 4, 2021
“Regenerative medicine news under the microscope” is a monthly feature highlighting big stories in stem cell research. I will sample the latest and greatest findings in recent press and package them into a single post. This month, I cover a technologically advanced...
by Lyla El-Fayomi | Oct 1, 2021
“Regenerative medicine news under the microscope” is a monthly feature highlighting big stories in stem cell research. I will sample the latest and greatest findings in recent press and package them into a single post. It seems that I say this every month, but wow....
Comments